Indometacin Laropharm

Indometacin, the active ingredient in Indometacin Laropharm, is a nonsteroidal anti‑inflammatory drug (NSAID) presented as an oral formulation for oral use. It is used to reduce pain and inflammation in conditions such as rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, gout and other musculoskeletal disorders.

GNH USA supplies Indometacin Laropharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Indometacin acts on inflammatory pathways to relieve pain and swelling in several musculoskeletal diseases.

Rheumatoid arthritis: reduces joint pain, swelling and stiffness. Osteoarthritis: alleviates chronic joint pain and improves function. Ankylosing spondylitis: decreases spinal inflammation and stiffness. Gout: relieves acute gouty arthritis pain and inflammation. Pain and inflammation: provides symptomatic relief in various inflammatory conditions.

Indometacin may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Gastrointestinal upset, including nausea and dyspepsia. - Headache or dizziness. - Mild abdominal discomfort. - Transient elevation of liver enzymes.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Acute renal impairment or failure. - Severe skin reactions such as Stevens‑Johnson syndrome. - Anaphylactic or severe hypersensitivity reactions. - Hepatic dysfunction with jaundice. - Increased risk of cardiovascular thrombotic events.

Before prescribing Indometacin, clinicians should evaluate patient‑specific risk factors and monitor for adverse events.

Assess renal function: check baseline creatinine and monitor periodically. Monitor hepatic enzymes: watch for signs of liver injury. Evaluate gastrointestinal risk: consider ulcer prophylaxis in high‑risk patients. Use the lowest effective dose: limit duration to reduce toxicity. Avoid in known hypersensitivity: discontinue if allergic reactions occur. Store at room temperature: keep in the original pack, protect from moisture.

Indometacin can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Warfarin or other anticoagulants: increased bleeding risk. - Concomitant NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity. - ACE inhibitors or ARBs: possible reduction in renal function.

Moderate Interactions (Monitor Closely): - SSRIs or SNRIs: additive bleeding tendency. - Diuretics: may enhance renal adverse effects. - Lithium: potential increase in lithium serum levels.